Prosecution Insights
Last updated: May 29, 2026

Genfit

6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (50%)
0
Easy (0%)
3
Unknown (50%)

Rejection Statute Mix

BucketCases
§103 only3 (50%)
No statute on record3 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NEWTON, CHAD A 1 36.9% +25.4%
FETTEROLF, BRANDON J 1 49.5% +14.6%
PIHONAK, SARAH 1 60.9% +43.4%
DHARITHREESAN, NIDHI 1 40.4% +37.6%
YU, DELPHINUS DOU YI 1 0.0% +0.0%
SITTON, JEHANNE SOUAYA 1 52.9% +47.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17603347 COMPOSITIONS AND METHODS FOR THE STABILIZATION OF MICRO-RNA YU, DELPHINUS DOU YI 34d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18569619 METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER NEWTON, CHAD A 43d overdue
17237789 QUANTITATIVE DETECTION OF MICRO-RNAS SITTON, JEHANNE SOUAYA 32d overdue
17849161 METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS DHARITHREESAN, NIDHI 8d overdue
18289511 NITAZOXANIDE IN THE TREATMENT OF SEPSIS FETTEROLF, BRANDON J 4d overdue
18252760 METHODS OF TREATMENT OF LIVER FAILURE PIHONAK, SARAH 30d

Top Art Units

Art UnitApps
3681 1
1626 1
1627 1
1686 1
1636 1
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18569619 METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER NEWTON, CHAD A 3681 §103 Final Rejection 43d overdue Pending Dec 13, 2023
18289511 NITAZOXANIDE IN THE TREATMENT OF SEPSIS FETTEROLF, BRANDON J 1626 Other Non-Final OA 4d overdue Pending Nov 03, 2023
18252760 METHODS OF TREATMENT OF LIVER FAILURE PIHONAK, SARAH 1627 Other Non-Final OA 30d Pending May 12, 2023
17849161 METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS DHARITHREESAN, NIDHI 1686 Other Non-Final OA 8d overdue Pending Jun 24, 2022
17603347 COMPOSITIONS AND METHODS FOR THE STABILIZATION OF MICRO-RNA YU, DELPHINUS DOU YI 1636 §103 Final Rejection 34d Pending Oct 13, 2021
17237789 QUANTITATIVE DETECTION OF MICRO-RNAS SITTON, JEHANNE SOUAYA 1682 §103 Final Rejection 32d overdue Pending Apr 22, 2021

Managing Genfit's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month